
Optical genome mapping detects abnormalities in 97.8% of T-ALL cases, doubling conventional methods' detection rate.
Bionano Genomics published a study showing optical genome mapping (OGM) identified genomic abnormalities in 97.8% of T-cell acute lymphoblastic leukemia (T-ALL) cases, nearly doubling the 55% detection rate of traditional cytogenetic analysis. The st...
